eNauka - pregled

Pregled prema Projekat G1 Therapeutics, Inc

Prikaz rezultata 1 do 5 od 5
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2021Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancerDomine, Gomez Manuel; Csoszi, Tibor; Jaal, Jana; Kudaba, Iveta; Nikolov, Krassimir; Radosavljevic, Davorin Z; Xiao, Jie; Horton, Janet K; Malik, Rajesh K; Subramanian, JanakiramanNaučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2020Myelopreservation and reduced use of supportive care with trilaciclib in patients with small cell lung cancer.Jared, Weiss; Jerome, Goldschmidt; Andric, Zoran G  ; Konstantin, Dragnev H; Yili, Pritchett; Shannon, Morris R; Rajesh, Malik K; Davey, Daniel BКонференцијски рад
Мп категорија ће бити приказана накнадно.
2021Trial in progress: A phase 3, randomized, double-blind trial of trilaciclib versus placebo in patients receiving first- or second-line gemcitabine and carboplatin for locally advanced unresectable or metastatic triple-negative breast cancer (PRESERVE 2).Goel, Shom; O'Shaughnessy, Joyce; Tan, Antoinette R; Milev-Krastev, Boris; Rugo, Hope S; Aftimos, Philippe Georges; Yardley, Denise A; Andric, Zoran G  ; Wolfgang, Curt Douglas; Sorrentino, Jessica;
Tao, Wenli; Beelen, Andrew Paul; Malik, Rajesh K; Jain, Sarika;
Conference Paper
Mp. category will be shown later
2019Trilaciclib improves overall survival when given with gemcitabine/carboplatin (GC) in patients with metastatic triple negative breast cancer (mTNBC) in a randomized phase II trialO'Shaughnessy, J; ...; Popovic, Lazar S  ; ...; Milenkovic, Dusan M; ...; (broj, koautora 17)Конференцијски рад
Мп категорија ће бити приказана накнадно.
2022Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II StudyTan, Antoinette R; Wright, Gail; Thummala, Anu; Danso, Michael; Popovic, Lazar S  ; Pluard, Timothy; ...et al.; Milenkovic, Dusan M; (broj, koautora 17)Article
21a+M21a+